Eli Lilly Dan Skovronsky discusses weight loss drugs

Dan Skovronsky knows what a good drug of obesity does. As head of scientific officer in Eli LillyHe has already…

ELI LILY (LLY) Q4 2024 earnings

Eli Lilly reported mixed results for the fourth quarter on Thursday, even when the demand for its great success of…

CEO Lars Fruergaard Jorgensen discusses Wegovy

They have been a few rocky months to Novo Nordisk. IQVIA prescription data suggest that the Novo Wegovy Obesity Medication…

Foods like new medical companies could benefit

Robert Kennedy Jr., nominated for the president of the United States, Donald Trump, to direct the Department of Health and…